Journal of Experimental and Clinical SurgeryJournal of Experimental and Clinical Surgery2070-478X2409-143XVoronezh State Medical University68210.18499/2070-478X-2010-3-2-129-132UnknownBasis of systematic lymph mediastinal bilateral dissection in the surgical treatment of non-small cell carcinoma of lung.author@vestnik-surgery.com.author@vestnik-surgery.com.24062010321291321805201618052016Copyright © 2010, ., .2010The systematic lymph dissection, a drastic treatment procedure in the surgical treatment of lung carcinoma, is declared to be an operative procedure helping to assess the true extent of a neoplastic [tumor] process. From the 300 operative interventions the 150 (50,0%) came to “expanded” operations which were followed by a systematic lymph dissection from principal considerations. The other 150 (50,0%) patients were operated typically without any systematic mediastinal lymph dissection. The general five-year probability of survival (equal to 35%), while the postoperative lethality is equal to 6,7%, speaks for a surgical assistance of a good quality in the clinical hospital. To present day 254 (85,0% from the 300) patients have been watched over.carcinoma of lungtreatmentprobability of survivalрак лёгкоголечениевыживаемость[1. Davydov M.I., Polotskii B.E. Sovremennye aspekty][epidemiologii, semiotiki i lecheniia raka legkogo.][Ter. arkh. 1990; 62: 10: 58 – 63.][2. Davydov M.I., Polotskii B.E. Rak legkogo. M: Radiks][1994; 216.][3. Dvoirin V.V., Trapeznikov N.N. Statistika raka legko-][go v Rossii. Vestnik Onkologicheskogo nauchnogo tsen-][tra im. N.N. Blokhina 1996; 2: 3 – 12.][4. Trakhtenberg A.Kh. Rak legkogo. M: Meditsina 1987; 304.][5. Bergmans T., Sculier J.P., Klastersky J. A prospective][study of infections in lung cancer patients admitted to the][hospital. Chest 2003; 124: 1: 114-120.][6. Bernet F., Brodbeck R., Guenin M. O., Schupfer G. Age][does not influence early and late tumor-related outcome for][bronchogenic carcinoma [see comments]. Ann Thorac Surg][2000; 69: 3: 913-918.][7. Brown J.S., Eraut D., Trask C. Age and the treatment of][lung cancer. Thorax 1996; 51: 564-568.][8. Harvey J.C., Beattie E.J. Lung cancer and other selected][topics in thoracic oncology. Semin Surg Oncol 1993; 9: 71][–162.][9. Martin J., GinsbergR.J., Venkatraman E.S. et al. Longterm][results of combined-modality therapy in resectable][non-small-cell lung can cer. Clin Oncol 2002; 15: 20: 8:][1989-1995.][10. Minami H, Yoshimura M., Matsuoka H, Toshihiko S. Lung][cancer treated surgically in patients <50 years of age. Chest][2001; 120:1: 32–36.][11. Muers M.F., Howard R.A. Management of lung cancer.][Thorax 1996; 51; 557-560.][12. OkadaM., YoshikawaK., Hatta T., Tsubota N.][Issegmentectomy with lymph node assessment an][alternative to lobectomy for non-small cell lung cancer of 2][cm or smaller? Ann Thorac Surg 2001; 71: 956—960.][13. Wingo P.A., Ries L.A., Rosenberg H.M. Cancer incidence][and mortal ity, 1973–1995: A report card for the US. Cancer][1998; 82: 1197 1207.]